These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10544941)

  • 21. Efficacy, safety and pharmacokinetics of a new high-purity factor X concentrate in subjects with hereditary factor X deficiency.
    Austin SK; Kavakli K; Norton M; Peyvandi F; Shapiro A;
    Haemophilia; 2016 May; 22(3):419-25. PubMed ID: 27197801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resolution of factor X deficiency in primary amyloidosis following splenectomy.
    Rosenstein ED; Itzkowitz SH; Penziner AS; Cohen JI; Mornaghi RA
    Arch Intern Med; 1983 Mar; 143(3):597-9. PubMed ID: 6830397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Syndrome of acquired factor X deficiency and systemic amyloidosis; in vivo studies of the metabolic fate of factor X.
    Furie B; Greene E; Furie BC
    N Engl J Med; 1977 Jul; 297(2):81-5. PubMed ID: 865580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acquired factor X deficiency in systemic amyloidosis: management of two cases.
    Chaudhary P; Wakim J; Khadim H; Karumbaiah KK; Gajra A
    Haemophilia; 2013 Nov; 19(6):e375-6. PubMed ID: 24033815
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacokinetics of a high-purity plasma-derived factor X concentrate in subjects with moderate or severe hereditary factor X deficiency.
    Austin SK; Brindley C; Kavakli K; Norton M; Shapiro A;
    Haemophilia; 2016 May; 22(3):426-32. PubMed ID: 26879266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acquired factor X deficiency. Altered plasma antithrombin activity and association with amyloidosis.
    Galbraith PA; Sharma N; Parker WL; Kilgour JM
    JAMA; 1974 Dec 23-30; 230(12):1658-60. PubMed ID: 4479863
    [No Abstract]   [Full Text] [Related]  

  • 27. Recombinant human factor VIIa in the management of amyloid-associated factor X deficiency.
    Boggio L; Green D
    Br J Haematol; 2001 Mar; 112(4):1074-5. PubMed ID: 11298609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prolonged prothrombin time: don't overlook amyloidosis].
    Abdulahad J; Lamy T; Costa B; Seyrig JA
    Gastroenterol Clin Biol; 2002; 26(6-7):639-40. PubMed ID: 12193869
    [No Abstract]   [Full Text] [Related]  

  • 29. Spontaneous rupture of the spleen in AL amyloidosis.
    Oran B; Wright DG; Seldin DC; McAneny D; Skinner M; Sanchorawala V
    Am J Hematol; 2003 Oct; 74(2):131-5. PubMed ID: 14508801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A deficiency of blood coagulation factor X in a female patient with primary generalized amyloidosis].
    Androsova SO; Kozlovskaia LV; Lavrova ON; Miroshnichenko NG
    Ter Arkh; 1994; 66(6):68-9. PubMed ID: 7940374
    [No Abstract]   [Full Text] [Related]  

  • 31. [Factor X deficiency in amyloidosis (author's transl)].
    Guérin JM
    Sem Hop; 1982 Feb; 58(7):421-2. PubMed ID: 6280316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acquired factor X deficiency and amyloidosis.
    Krause JR
    Am J Clin Pathol; 1977 Feb; 67(2):170-3. PubMed ID: 836622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Systemic light chain amyloidosis with acquired factor X deficiency: a case report].
    Li L; Zhou F; Hou J
    Zhonghua Xue Ye Xue Za Zhi; 2012 Jul; 33(7):506. PubMed ID: 22967401
    [No Abstract]   [Full Text] [Related]  

  • 34. Mechanism of factor X deficiency in systemic amyloidosis.
    Furie B; Voo L; McAdam KP; Furie BC
    N Engl J Med; 1981 Apr; 304(14):827-30. PubMed ID: 7207512
    [No Abstract]   [Full Text] [Related]  

  • 35. [Factor X deficiency in systemic amyloidosis. Presentation of a case].
    Ribera C; Delgado JM; Toledo T; Martín MA; Bornstein R; Fernández F
    Rev Clin Esp; 1986 Oct; 179(6):302-4. PubMed ID: 3797735
    [No Abstract]   [Full Text] [Related]  

  • 36. Spontaneous resolution of acquired factor X deficiency in amyloidosis.
    le Quellec A; Sotto A; Ciurana AJ
    J Intern Med; 1993 Sep; 234(3):329-30. PubMed ID: 8354985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fatal bleeding due to acquired factor IX and X deficiency: a rare complication of primary amyloidosis; case report and review of the literature.
    Ericson S; Shah N; Liberman J; Aboulafia DM
    Clin Lymphoma Myeloma Leuk; 2014 Jun; 14(3):e81-6. PubMed ID: 24290671
    [No Abstract]   [Full Text] [Related]  

  • 38. Refractory hematuria from amyloidosis successfully treated by splenectomy.
    Ma JF; Coutre SE; Curet MJ; Brooks JD
    Urology; 2006 May; 67(5):1085.e13-5. PubMed ID: 16698382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bortezomib-based treatment can improve factor X activity in immunoglobulin light-chain amyloidosis with factor X deficiency.
    Wu X; Miao HL; Zhu TN; Feng J; Zhang L; Mao YY; Zhou DB; Cao XX; Li J
    Amyloid; 2019 Dec; 26(4):255-256. PubMed ID: 31526149
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of amyloidosis associated factor X deficiency.
    Spero JA; Lewis JH; Hasiba U; Ellis LD
    Thromb Haemost; 1976 Apr; 35(2):377-81. PubMed ID: 989637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.